Latest news with #NationalBreastCancerResearchInstitute
The Journal
21-07-2025
- Sport
- The Journal
Tennis events raise over €165,000 for cancer care - and they're looking for more clubs to join
TENNIS TOURNAMENTS AND events held across Ireland have raised over €165,000 for cancer care, support, and research so far this year. Tennis4Cancer (T4C) is a fundraising initiative launched by tennis coach Grace Owens. Its aim is to rally the tennis community across Ireland to support two cancer charities: ARC Cancer Support Centres and the National Breast Cancer Research Institute. The amount raised will be evenly split between both charities. Since 2019, local tennis clubs from all over the country have raised funds by organising a range of different activities from coffee mornings to grand slam tournaments. T4C was established after a number of people in the tennis community had been affected by cancer. Over 40 clubs are now involved. Owens is appealing for more tennis clubs across the country to become involved with the fundraising. Clubs across Ireland have hosted 'a variety of events' to support the initiate, and more are expected to join in before the end of the year. Advertisement The Tennis4Cancer campaign is officially supported by Tennis Ireland and Tennis Coach Ireland. Conor Niland, former Irish No.1 and ex-ATP Tour professional, is the patron of the campaign. Owens said that she is 'delighted' at the response to the campaign and the funds already raised. 'In April, we held our 'Tennis4Cancer Weekender', which got our fundraising year off to a great start. 'Over 40 Tennis Clubs from all over the country have come together since then to host a variety of fun fundraising tennis events. 'It's great to see the tennis community coming together to support these two great cancer charities, Arc and NBCRI, and I would love to have lots more clubs involved between now and the end of the year,' she said. ARC Cancer Support Centres offer free professional support services, including counselling and complementary therapies, to adults and children affected by cancer and to their loved ones. The National Breast Cancer Research Institute funds groundbreaking breast cancer research based at the Lambe Institute, University of Galway. Readers like you are keeping these stories free for everyone... A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article. Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation. Learn More Support The Journal
Irish Examiner
15-05-2025
- Health
- Irish Examiner
€4m invested for life-changing research into breast cancer
A €4m investment into research for life-changing advancements in breast patient outcomes at the University of Galway has been announced. The funding from the National Breast Cancer Research Institute (NBCRI) is to enable enhanced research and diagnostics including digital imaging currently not available in Ireland. It will also see the expansion of clinical trials, more international collaboration on the analysis of clinical samples and the appointment of academic and research roles. Minister for Health Jennifer Carroll MacNeill hailed an 'important step forward' in tackling a disease that one in seven women in Ireland will receive a diagnosis of. She said she was delighted to launch the partnership between the NBCRI and the University of Galway. 'This investment of €4m in breast cancer research will not only enhance patient care and outcomes but also pave the way for ground breaking advancements in research and diagnostics,' she said. 'As breast cancer is one of the most common cancers, with one in seven women in Ireland receiving a diagnosis during their lifetime, today's announcement marks another important step forward in supporting women affected by this disease.' Professor Peter McHugh, interim president of the University of Galway, said he expects the research will auger a significance difference to outcomes for cancer patients. 'Our partnership goes back many years and we have no doubt that this generous philanthropic investment will make a significant difference to outcomes for cancer patients, as well as the wider impact that our University can have as a research-intensive institution, rooted in the community and committed to the public good,' he said. NBCRI chairwoman Caroline Loughnane said her organisation's mission is to raise funds in support of world-class breast cancer research that has a real and measurable impact on outcomes for breast cancer patients. 'We are delighted to be making this investment of €4m in the breast cancer research programme at University of Galway, led by Professor Michael Kerin and his team,' she said. 'Research means new discoveries, more effective treatments and better outcomes for breast cancer patients. 'Building on more than three decades of support, NBCRI is excited to extend its commitment to the breast cancer research programme at University of Galway as it enters a new phase as a European accredited cancer centre in partnership with the HSE West and North-West.' Prof Kerin added that the funding underpins an expansive programme of research and builds on the legacy of the NBCRI contribution to major discoveries in breast cancer ranging from the genes that cause it, biomarkers that predict outcome, improved radiological interpretation. 'It has allowed us to contribute to major clinical and research collaborations on this island and across the globe,' he said. 'The research team are immensely grateful to our board and volunteers whose support is immense and inspirational.' University of Galway's longstanding relationship with NBCRI has enabled approximately €8m of philanthropic funding and investment in research at the Lambe Institute at the University since 2010.
Belfast Telegraph
15-05-2025
- Health
- Belfast Telegraph
Four million euro invested for life-changing research into breast cancer
The funding from the National Breast Cancer Research Institute (NBCRI) is to enable enhanced research and diagnostics including digital imaging currently not available in Ireland. It will also see the expansion of clinical trials, more international collaboration on the analysis of clinical samples and the appointment of academic and research roles. Minister for Health Jennifer Carroll MacNeill hailed an 'important step forward' in tackling a disease that one in seven women in Ireland will receive a diagnosis of. She said she was delighted to launch the partnership between the NBCRI and the University of Galway. 'This investment of four million euro in breast cancer research will not only enhance patient care and outcomes but also pave the way for ground breaking advancements in research and diagnostics,' she said. 'As breast cancer is one of the most common cancers, with one in seven women in Ireland receiving a diagnosis during their lifetime, today's announcement marks another important step forward in supporting women affected by this disease.' Professor Peter McHugh, interim president of the University of Galway, said he expects the research will auger a significance difference to outcomes for cancer patients. 'Our partnership goes back many years and we have no doubt that this generous philanthropic investment will make a significant difference to outcomes for cancer patients, as well as the wider impact that our University can have as a research-intensive institution, rooted in the community and committed to the public good,' he said. NBCRI chairwoman Caroline Loughnane said her organisation's mission is to raise funds in support of world-class breast cancer research that has a real and measurable impact on outcomes for breast cancer patients. 'We are delighted to be making this investment of four million euro in the breast cancer research programme at University of Galway, led by Professor Michael Kerin and his team,' she said. 'Research means new discoveries, more effective treatments and better outcomes for breast cancer patients. 'Building on more than three decades of support, NBCRI is excited to extend its commitment to the breast cancer research programme at University of Galway as it enters a new phase as a European accredited cancer centre in partnership with the HSE West and North-West.' Prof Kerin added that the funding underpins an expansive programme of research and builds on the legacy of the NBCRI contribution to major discoveries in breast cancer ranging from the genes that cause it, biomarkers that predict outcome, improved radiological interpretation. 'It has allowed us to contribute to major clinical and research collaborations on this island and across the globe,' he said. 'The research team are immensely grateful to our board and volunteers whose support is immense and inspirational.' University of Galway's longstanding relationship with NBCRI has enabled approximately eight million euro of philanthropic funding and investment in research at the Lambe Institute at the University since 2010.
RTÉ News
15-05-2025
- Health
- RTÉ News
€4m for Galway university to improve breast cancer research
The University of Galway is receiving €4 million in funding from the National Breast Cancer Research Institute to improve research and diagnostics as well as more clinical trials for breast cancer patients. Chair of Surgery at the university, Professor Michael Kerin, said that women in the west of Ireland have the highest incidence of breast cancer in the country. "We're challenged in delivering care in the west of Ireland because of the dispersion, social isolation, the distance between many of the patients and the institution," said. Prof Kerin added that University Hospital Galway, which houses the cancer centre, "has the most dilapidated and out-of-date facilities in the country, mainly due to the fact that it was built in 1953". "But we have a very progressive plan in place now and we've been accredited as a European cancer network ... so that while the cancer centre delivers complex care such as the surgery and radiotherapy ... then the care is given as close to home as possible. "This has huge implications for improving care for our population," Prof Kerin, who is a consultant surgeon at the hospital, told RTÉ's Morning Ireland. The funding, he said, will be used in a number of areas, including research on metastatic breast cancer, the genes that cause breast cancer and developing the biobank of patient samples. The Lambe Institute for Translational Research, which is based on the grounds of the hospital, has a large number of samples and these allow scientists, engineers and doctors to translate their findings "from the bench to the bedside to make real differences in outcomes for patients," Prof Kerin said. Asked about the cost of new cancer drugs, he said that "all aspects of cancer care are costly and the way to do it is in an integrated network ... around diagnostics, access to the operating room and access to drugs". Ireland's drugs bill has reached nearly €4 billion a year and "there are issues around ensuring that people get access to appropriate drugs," Prof Kerin said.
Irish Independent
15-05-2025
- Health
- Irish Independent
Four million euro invested for life-changing research into breast cancer
The funding from the National Breast Cancer Research Institute (NBCRI) is to enable enhanced research and diagnostics including digital imaging currently not available in Ireland. It will also see the expansion of clinical trials, more international collaboration on the analysis of clinical samples and the appointment of academic and research roles. Minister for Health Jennifer Carroll MacNeill hailed an 'important step forward' in tackling a disease that one in seven women in Ireland will receive a diagnosis of. She said she was delighted to launch the partnership between the NBCRI and the University of Galway. 'This investment of four million euro in breast cancer research will not only enhance patient care and outcomes but also pave the way for ground breaking advancements in research and diagnostics,' she said. 'As breast cancer is one of the most common cancers, with one in seven women in Ireland receiving a diagnosis during their lifetime, today's announcement marks another important step forward in supporting women affected by this disease.' Professor Peter McHugh, interim president of the University of Galway, said he expects the research will auger a significance difference to outcomes for cancer patients. 'Our partnership goes back many years and we have no doubt that this generous philanthropic investment will make a significant difference to outcomes for cancer patients, as well as the wider impact that our University can have as a research-intensive institution, rooted in the community and committed to the public good,' he said. NBCRI chairwoman Caroline Loughnane said her organisation's mission is to raise funds in support of world-class breast cancer research that has a real and measurable impact on outcomes for breast cancer patients. 'We are delighted to be making this investment of four million euro in the breast cancer research programme at University of Galway, led by Professor Michael Kerin and his team,' she said. ADVERTISEMENT 'Research means new discoveries, more effective treatments and better outcomes for breast cancer patients. 'Building on more than three decades of support, NBCRI is excited to extend its commitment to the breast cancer research programme at University of Galway as it enters a new phase as a European accredited cancer centre in partnership with the HSE West and North-West.' Prof Kerin added that the funding underpins an expansive programme of research and builds on the legacy of the NBCRI contribution to major discoveries in breast cancer ranging from the genes that cause it, biomarkers that predict outcome, improved radiological interpretation. 'It has allowed us to contribute to major clinical and research collaborations on this island and across the globe,' he said. 'The research team are immensely grateful to our board and volunteers whose support is immense and inspirational.' University of Galway's longstanding relationship with NBCRI has enabled approximately eight million euro of philanthropic funding and investment in research at the Lambe Institute at the University since 2010.
